ELVN icon

Enliven Therapeutics
ELVN

Overview Fund Activity

123 hedge funds and large institutions have $1.19B invested in Enliven Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 23 reducing their positions, and 20 closing their positions.

Holders
123
Holders Change
+2
Holders Change %
+1.65%
% of All Funds
1.65%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
24
Increased
56
Reduced
23
Closed
20
Calls
–
Puts
$14K
Net Calls
-$14K
Net Calls Change
+$3K

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$26.4M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$27.1M
3
NHAS
3
Novo Holdings A/S
Denmark
$21.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$152M
5
PCH
5
Polar Capital Holdings
United Kingdom
$61.2M

Top Sellers

1
BCM
1
Boxer Capital Management
California
$0
2
5VM
2
5AM Venture Management
California
$15.5M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.93M
4
IC
4
Ikarian Capital
Texas
$0
5
ACP
5
Acuta Capital Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Franklin Resources
26
Franklin Resources
California
$8.63M 430,240 +410,034 +2,029%
CS
27
Candriam SCA
Luxembourg
$8.36M 416,650 +416,650 New
AAA
28
Affinity Asset Advisors
New York
$8.02M 400,000 +400,000 New
LGM
29
Logos Global Management
California
$7.02M 350,000 +110,000 +46%
Marshall Wace
30
Marshall Wace
United Kingdom
$6.69M 333,333 +322,173 +2,887%
Northern Trust
31
Northern Trust
Illinois
$6.51M 324,628 -14,022 -4%
Millennium Management
32
Millennium Management
New York
$6.39M 318,449 +185,562 +140%
Charles Schwab
33
Charles Schwab
California
$6.13M 305,660 +46,123 +18%
ABG
34
Ally Bridge Group
New York
$5.64M 281,394 +111,620 +66%
Morgan Stanley
35
Morgan Stanley
New York
$5.11M 254,848 +173,533 +213%
VPC
36
Vestal Point Capital
New York
$5.02M 250,000 +250,000 New
PSC
37
Patient Square Capital
California
$4.93M 245,838 -8,000 -3%
CAM
38
Cormorant Asset Management
Massachusetts
$4.01M 200,000 -50,000 -20%
Goldman Sachs
39
Goldman Sachs
New York
$3.8M 189,505 -22,247 -11%
HS
40
HighVista Strategies
Massachusetts
$2.84M 141,516 +29,057 +26%
UBS Group
41
UBS Group
Switzerland
$2.77M 138,280 +67,844 +96%
SFM
42
Sphera Funds Management
Israel
$2.58M 128,515 +16,772 +15%
BBA
43
Baker Bros. Advisors
New York
$2.3M 114,833 – –
Bank of New York Mellon
44
Bank of New York Mellon
New York
$1.97M 98,129 +4,562 +5%
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
$1.93M 96,000 -354,000 -79%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$1.89M 94,012 +9,312 +11%
NL
47
Nuveen LLC
North Carolina
$1.8M 89,712 -14,387 -14%
UBS AM
48
UBS AM
Illinois
$1.67M 83,054 +47,156 +131%
Barclays
49
Barclays
United Kingdom
$1.46M 72,784 +22,427 +45%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$1.36M 67,864 +62,688 +1,211%
1
2
3 4 5